Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment.
The association of Chlamydia pneumoniae with pneumonia was first reported in 1985. This review summarizes the data collected during the subsequent 10 years on the prevalence, clinical features, diagnosis, and treatment of this disease, which is now associated with approximately 10% of all cases of pneumonia worldwide. Primary infections are documented most often in schoolchildren and young adults, while reinfections are prominent among the elderly. C. pneumoniae pneumonia is difficult to diagnose; its onset is often insidious, with nonpurulent sputum and without leukocytosis. The microbiological diagnosis is based on the results of serological tests, polymerase chain reaction, and culture. Tetracyclines and macrolides are effective in the treatment of C. pneumoniae pneumonia, as are new quinolones.
Kauppinen
M
M
Department of Oulu, National Public Health Institute, Finland.
Saikku
P
P
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000032:analysis; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D016993:Chlamydophila pneumoniae / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology*; D016036:Seroepidemiologic Studies
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial